NASDAQ
Cellectar Biosciences, Inc. (CLRB) has a free cash flow growth of -11.47% as of Friday, May 29, 2026. This represents a 161.45% decrease compared to its 12-month average of 18.66%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.